Mr. A, a 60-year-old Korean male patient, was diagnosed with gastric cancer several years ago. After struggling to treat the disease for several years, the hospital told A that there was no other treatment option available for him and that he may not be able to live for more than 6 months. As a last resort, A registered to enroll in the KOSMOS study and was told there was a breast cancer treatment available for the genetic mutation he was found with during genetic testing. The breast cancer drug stayed effective for over a year, and after seeing a significant reduction in tumor size, A left his hospital bed and was able to receive the outpatient treatment he had only dreamed of.

The stage has been set